Safety and efficacy of conditioning regimen with once-daily intravenous busulfan and fludarabine or cyclophosphamide for allogeneic hematopoietic stem cell transplantation in acute myelogenous leukemia or myelodysplastic syndrome
Not Applicable
Recruiting
- Conditions
- acute myelogenous leukemia, myelodysplastic syndrome
- Registration Number
- JPRN-UMIN000015647
- Lead Sponsor
- Second Department of Internal Medicine, Shinshu University of School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
patients with antibody of HIV patients has other malignancies patients has uncontrollable psychiatric disorders patients has active infections patients has history of hematopoietic stem cell transplantation patients has allergy of the drugs that use in protocol pregnant woman
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method event-free survival at day 100 from transplantation
- Secondary Outcome Measures
Name Time Method